-
EP1231910
European procedure
Extract from the Register of European Patents
EP About this file: EP1231910
| EP1231910 - PENTAMIDINE FOR TREATING CANCER [Right-click to bookmark this link] | |||
| Former [2002/34] | INHIBITORS OF ENDO-EXONUCLEASE ACTIVITY SUCH AS PENTAMIDINE FOR TREATING CANCER | ||
| [2008/32] | Status | No opposition filed within time limit Status updated on 26.03.2010 Database last updated on 27.07.2024 | Most recent event Tooltip | 17.12.2010 | Change - lapse in a contracting state State(s) deleted from list of lapses: MC | published on 19.01.2011 [2011/03] | Applicant(s) | For all designated states Oncozyme Pharma Inc. 6252 Des Galleries d'Anjou Blvd. Anjou, Quebec H1M 1V8 / CA | [2002/34] | Inventor(s) | 01 /
CHOW, Terry 6252 Des Galleries d'Anjou Blvd. Anjou, Quebec H1M 1V8 / CA | 02 /
YEH, Chiaoli 6252 Des Galleries d'Anjou Blvd. Anjou, Quebec H1M 1V8 / CA | 03 /
GRILLER, David 2026 Delmar Court Ottawa, Ontario K1H 5R7 / CA | 04 /
YUEN, Leonard 639 Lajeunesse St. Laval, Quebec H7X 3K5 / CA | [2002/34] | Representative(s) | Bassil, Nicholas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2003/01] | Bassil, Nicholas Charles, et al Kilburn & Strode 20 Red Lion Street London WC1R 4PJ / GB | ||
| Former [2002/50] | Addison, Ann, et al Kilburn & Strode, 20 Red Lion Street London WC1R 4PJ / GB | ||
| Former [2002/34] | Gervasi, Gemma, Dr., et al NOTARBARTOLO & GERVASI Corso di Porta Vittoria, 9 20122 Milano / IT | Application number, filing date | 00975725.3 | 16.11.2000 | [2002/34] | WO2000CA01355 | Priority number, date | US19990165688P | 16.11.1999 Original published format: US 165688 P | [2002/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0135935 | Date: | 25.05.2001 | Language: | EN | [2001/21] | Type: | A2 Application without search report | No.: | EP1231910 | Date: | 21.08.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.05.2001 takes the place of the publication of the European patent application. | [2002/34] | Type: | B1 Patent specification | No.: | EP1231910 | Date: | 20.05.2009 | Language: | EN | [2009/21] | Search report(s) | International search report - published on: | EP | 03.01.2002 | Classification | IPC: | A61K31/155, A61K31/70, A61K31/404, A61K33/24, A61K39/395, A61P35/00 | [2008/32] | CPC: |
A61K45/06 (EP,US);
A61K31/155 (EP,US);
A61K31/337 (EP,US);
A61K33/243 (EP,US);
A61P35/00 (EP)
| C-Set: |
A61K31/155, A61K2300/00 (EP,US);
A61K31/337, A61K2300/00 (US,EP);
A61K33/24, A61K2300/00 (US,EP)
|
| Former IPC [2002/34] | A61K31/155, A61K31/70, A61K33/24, A61K31/404, A61K31/196, A61K31/513, A61P35/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/34] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | PENTAMIDINE ZUR BEHANDLUNG VON KREBS | [2008/32] | English: | PENTAMIDINE FOR TREATING CANCER | [2008/32] | French: | PENTAMIDINE POUR LE TRAITEMENT DU CANCER | [2008/32] |
| Former [2002/34] | HEMENDER VON ENDO-EXONUCLEASEAKTIVITÄT WIE PENTAMIDINE ZUR BEHANDLUNG VON KREBS | ||
| Former [2002/34] | INHIBITORS OF ENDO-EXONUCLEASE ACTIVITY SUCH AS PENTAMIDINE FOR TREATING CANCER | ||
| Former [2002/34] | INHIBITEURS DE L'ACTIVITE DES ENDO-EXONUCLEASES DESTINES AU TRAITEMENT DU CANCER | Entry into regional phase | 14.06.2002 | National basic fee paid | 14.06.2002 | Designation fee(s) paid | 14.06.2002 | Examination fee paid | Examination procedure | 24.05.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 14.06.2002 | Examination requested [2002/34] | 04.09.2003 | Despatch of a communication from the examining division (Time limit: M04) | 05.01.2004 | Reply to a communication from the examining division | 30.03.2005 | Despatch of a communication from the examining division (Time limit: M06) | 10.10.2005 | Reply to a communication from the examining division | 01.06.2006 | Despatch of a communication from the examining division (Time limit: M06) | 08.11.2006 | Reply to a communication from the examining division | 21.04.2008 | Despatch of a communication from the examining division (Time limit: M02) | 26.06.2008 | Reply to a communication from the examining division | 23.07.2008 | Communication of intention to grant the patent | 10.11.2008 | Fee for grant paid | 10.11.2008 | Fee for publishing/printing paid | 09.01.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | Opposition(s) | 23.02.2010 | No opposition filed within time limit [2010/17] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 09.03.2009 | Request for further processing filed | 09.03.2009 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 23.10.2002 | Renewal fee patent year 03 | 12.11.2003 | Renewal fee patent year 04 | 12.11.2004 | Renewal fee patent year 05 | 14.11.2005 | Renewal fee patent year 06 | 14.11.2006 | Renewal fee patent year 07 | 15.11.2007 | Renewal fee patent year 08 | 27.11.2008 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2011/03] |
| Former [2010/30] | MC | 30.11.2009 | Cited in | International search | [AX]DE2145528 (MACK CHEM PHARM) [A] 10,12,19,21,26,28 * page 1, paragraph 1 - paragraph 4 * [X] 32,33; | [XA]US5084480 (PAI SADANAND [US], et al) [X] 1,2 * column 4, line 14 - line 52 * [A] 7,8; | [XA]US5204113 (HARTLEY PHILIP S [GB], et al) [X] 1,2 * column 1, line 15 - line 26 * [A] 10,11; | [X] - PEREZ J M ET AL, "Binding of Pt-pentamidine to nucleosomal DNA. Studies of the antiproliferative activity of the drug against human cancer cells.", CHEMICO-BIOLOGICAL INTERACTIONS, (1993), vol. 89, no. 1, ISSN 0009-2797, pages 61 - 72, XP010225183 [X] 1,2,10,11,13-20,22-27,29-31 * page 68, paragraph 2 * * page 70, paragraph 3 - page 71, paragraph 1 * | [A] - DE LUCA ANTONELLA ET AL, "Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.", INTERNATIONAL JOURNAL OF CANCER, (1997), vol. 73, no. 2, ISSN 0020-7136, pages 277 - 282, XP001025184 [A] 3,5,6,12,14,15,21-25,28-31 * page 280, paragraph 2 * DOI: http://dx.doi.org/10.1002/(SICI)1097-0215(19971009)73:2<277::AID-IJC19>3.0.CO;2-C | [X] - TUAN I -Z ET AL, "Pneumocystis carinii pneumonitis following bone marrow transplantation.", BONE MARROW TRANSPLANTATION, (1992), vol. 10, no. 3, ISSN 0268-3369, pages 267 - 272, XP010225159 [X] 1,2 * page 270, column 1, paragraph 3 * * page 271, column 1 * | [X] - WAALKES T P ET AL, "PENTAMIDINE CLINICAL PHARMACOLOGIC CORRELATIONS IN MAN AND MICE", CLINICAL PHARMACOLOGY & THERAPEUTICS, (1970), vol. 11, no. 4, ISSN 0009-9236, pages 505 - 512, XP001025185 [X] 1,2 * page 510, column 1, paragraph 1 * | Examination | US5204352 | - DIMARCO A. ET AL, "Experimental studies on distamycin A - a new antibiotic with cytotoxic activity", CANCER CHEMOTHERAPY REPORTS, (196205), no. 18, pages 15 - 19, XP009045455 |